Aims To investigate the mechanisms of action of natural products with bactericidal
(cinnamon root powder, peppermint oil, trans‐cinnamaldehyde, menthol and zingerone) or …

Aims To investigate the antimicrobial activity of various natural products against Clostridium
difficile in vitro. Methods and Results The antibacterial activity of 20 natural products was …

Aims There is a need for novel treatments for Clostridium difficile infection (CDI).
Antibacterial flavonoids are part of a large family of polyphenol phytochemicals with a long …

Aims To investigate the effect of natural products on the spore cycle of Clostridium difficile in
vitro. Methods and Results Twenty‐two natural products were investigated using four C …

Clostridium difficile infection is a toxin-mediated disease of the colon. C. difficile virulence is
primarily attributed to the production of toxin A and toxin B; thus this study was aimed to …

Clostridium difficile is a nosocomial pathogen that causes a serious toxin-mediated enteric
disease in humans. Reducing C. difficile toxin production could significantly minimize its …

Clostridioides difficile infection is a global health threat and remains the primary cause of
hospital-acquired infections worldwide. The burgeoning incidence and severity of infections …

Clostridium difficile, a highly drug-resistant Gram-positive, spore-forming bacterium, remains
a leading cause of hospital-acquired diarrhoea and antibiotic-associated colitis. Clinically …

Clostridium difficile is an anaerobic, Gram-positive pathogen that causes C. difficile infection,
which results in significant morbidity and mortality. The incidence of C. difficile infection in …

Purpose. Clostridium difficile is an anaerobic spore-forming pathogen that causes a serious
toxin-mediated enteric disease in humans. Therapeutic agents that are capable of reducing …